Abstract
Hasenclever, H. F. (National Institutes of Health, Bethesda, Md.) and William O. Mitchell. Production in mice of tolerance to the toxic manifestations of Candida albicans. J. Bacteriol. 84:402–409. 1962. — Lethal toxic manifestations of Candida albicans in mice were demonstrated by the intravenous injection of 107 viable yeast cells. Untreated control animals had an average survival time of 4.5 to 10 hr after challenge. No multiplication of C. albicans could be demonstrated in the tissues of untreated infected controls 12 hr after challenge. Mice infected ip with C. albicans 6 days before iv challenge survived for periods three to four times longer than controls. Mice previously infected with other fungi also demonstrated tolerance to the toxicity of C. albicans. Coccidioides immitis and C. stellatoidea were especially effective. High-titer rabbit antiserum to viable C. albicans yeast cells was not protective. Studies of total and differential peripheral leukocytes indicated that mice in the tolerant state demonstrated a slight granulocytosis. Direct evidence of the protective effect of the granulocytic response was not shown
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HEDGECOCK L. W. Effect of vaccines prepared from Histoplasma capsulatum and other yeasts on experimental tuberculosis. J Bacteriol. 1961 Jul;82:115–123. doi: 10.1128/jb.82.1.115-123.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOURIA D. B., BROWNE H. G. The effects of cortisone on experimental fungus infections. Ann N Y Acad Sci. 1960 Aug 27;89:39–46. doi: 10.1111/j.1749-6632.1960.tb20128.x. [DOI] [PubMed] [Google Scholar]
- LOURIA D. B. Specific and non-specific immunity in experimental cryptococcosis in mice. J Exp Med. 1960 May 1;111:643–665. doi: 10.1084/jem.111.5.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOURAD S., FRIEDMAN L. Active immunization of mice against Candida albicans. Proc Soc Exp Biol Med. 1961 Mar;106:570–572. doi: 10.3181/00379727-106-26405. [DOI] [PubMed] [Google Scholar]
- MOURAD S., FRIEDMAN L. Pathogenicity of Candida. J Bacteriol. 1961 Apr;81:550–556. doi: 10.1128/jb.81.4.550-556.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROTH F. J., Jr, MURPHY W. H., Jr Lethality of cell-free extract of Candida albicans for chlortetracycline-treated mice. Proc Soc Exp Biol Med. 1957 Mar;94(3):530–532. doi: 10.3181/00379727-94-23002. [DOI] [PubMed] [Google Scholar]
- SALVIN S. B. Endotoxin in pathogenic q fungi. J Immunol. 1952 Jul;69(1):89–99. [PubMed] [Google Scholar]
- SHELDON W. H., BAUER H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med. 1959 Dec 1;110:845–852. doi: 10.1084/jem.110.6.845. [DOI] [PMC free article] [PubMed] [Google Scholar]